简体
简体中文
繁體中文

Nutriband Inc Warrants (30/09/2026) NTRBW

已收盘 12-19 16:00:00 美东时间

0.00

-1.480

-100.00%

华盛通华盛通
立即下载
  • 最 高0.00
  • 今 开0.00
  • 成交量 0股
  • 最 低 0.00
  • 昨 收 1.48
  • 总市值 0
  • 52周最高 5.12
  • 市盈率 --
  • 换手率 NaN.00%
  • 52周最低 0.00
  • 委 比 25.00%
  • 总股本 --
  • 历史最高 9.00
  • 量 比 0
  • 振 幅 0.00%
  • 历史最低 0.00
  • 每 手 1
  • 风险率 0.53%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

    Nutriband Inc. announced the issuance of a U.S. patent for its AVERSA™ abuse deterrent transdermal technology, expanding intellectual property coverage in the U.S. The technology aims to prevent drug abuse, diversion, and misuse through transdermal patches. Nutriband's lead product, Aversa™ Fentanyl, has the potential to become the first abuse deterrent pain patch, with estimated annual sales reaching $80 million to $200 million.

    06-09 11:30

  • Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference

    <p>Nutriband Inc. announces that CEO Gareth Sheridan will present at Noble Capital Markets’ virtual conference on June 5th, 4PM EST. The presentation includes a Q&A session and 1x1 investor meetings. A webcast will be available on the company’s website and Channelchek for 90 days.</p>

    06-03 12:00